ASCIA News
-
ASCIA Immunotherapy and Venom Allergy Updates
12 August 2020: The updated 2020 version of the ASCIA Subcutaneous Immunotherapy (SCIT) treatment plan is now on the ASCIA website www.allergy.org.au/hp/papers/scit-treatment-plan Another addition is a new quick-link to ASCIA insect and tick allergy resources on the ASCIA we... -
COVID-19 and Face Masks
3 August 2020: From Monday 3 August 2020, if you live in Victoria you must wear a face covering whenever you leave your home, unless an excemption applies. A face covering needs to cover both your nose and mouth. It could be a face mask or shield. For details go to https://w... -
COVID-19 and Allergy
3 August 2020: It is important that people with allergic rhinitis (hay fever) and asthma are using their treatments regularly and correctly, to maintain good health and prevent respiratory symptoms that can include coughing, sneezing and wheezing. With recent outbreaks of CO... -
Another AIFA grant recipient receives NHMRC funding
23 July 2020: For the third time since the Allergy and Immunology Foundation of Australasia (AIFA) started funding research grants in 2015, we are proud to announce that an AIFA grant recipient has received National Health and Medical Research Council (NHMRC) funding. Dr Sid... -
ASCIA CSU Update
13 July 2020: Further to updates made in 2019, the ASCIA Chronic Spontaneous Urticaria (CSU) Position Paper and ASCIA CSU Treatment Guidelines for Australia have recently been updated, in response to difficulties in sourcing H2 antagonists. The following statement has been i... -
ASCIA HAE Update
13 July 2020: Further to updates made in early 2020, the ASCIA Hereditary Angioedema (HAE) Position Paper has recently been updated in response to the New Zealand Minister of Health’s recent consent to the distribution of lanadelumab (published in the New Zealand Gazette on... -
ASCIA Highlights 2020
12 July 2020: Whilst 2020 has been challenging, work has continued on initiatives that support ASCIA’s Mission, to advance the science and practice of allergy and clinical immunology, by promoting the highest standard of medical practice, training, education and research, to... -
Updated ASCIA Guidelines for the Acute Management of Anaphylaxis
2 July 2020: In 2020 all ASCIA anaphylaxis resources and e-training courses have been reviewed and updated, and some new resources have been developed. This includes the recently updated ASCIA Guidelines for the Acute Management of Anaphylaxis, which are now on the ASCIA web...
-
Site updated: 12 Aug 2020
ASCIA Update
Information for the community about allergic diseases, immunodeficiencies and other immune diseases.
See latest edition here...
Join our mailing list here...
About ASCIA
ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases
Quick Links
About ASCIA
ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...
The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...
Disclaimer I Privacy
The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...
ASCIA respects your privacy. Read our privacy policy here...
Sponsors | Advertising
ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites.
The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.
Accreditiation
This site complies with the HONcode standard for trustworthy health information: verify here.